Recurring Adjusted EBITDA rose 14% year-over-year in 3Q25, with margin up to 20%. Net income declined 10% for the quarter but surged 85% for 9M25. Debt restructuring, strong cash position, and strategic projects support resilience amid challenging market conditions.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.